Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
07/1997
07/29/1997US5652252 Potassium channel activators
07/24/1997WO1997025985A1 Tracheal smooth muscle relaxant
07/17/1997WO1997025421A2 PROTEIN INDUCED BY DEPRENYL$m(3)
07/09/1997EP0783002A2 Dual action inhibitors
07/09/1997EP0782573A1 Drugs to improved synaptic transmission
07/09/1997CN1035379C Process for preparing e-caprolactone
07/08/1997US5646306 Process for controlled depolymerization of feed material to produce a product with lower molecular weight
07/08/1997US5646167 Arylsulfonamido-substituted hydroxamix acids
07/03/1997WO1997023475A1 Active compounds ii
06/1997
06/24/1997US5641805 Topical ophthalmic formulations for treating allergic eye diseases
06/17/1997US5639746 Inhibitors of metalloprotease
06/04/1997CN1150949A Preparation of unsaturated cyclic ethers
05/1997
05/29/1997WO1997019086A1 Epothilone derivatives, preparation and use
05/09/1997WO1997016438A1 Triterpene derivatives with immunosuppressant activity
05/09/1997WO1997016068A1 Triterpene derivatives with immunosuppressant activity
05/09/1997CA2236171A1 Triterpene derivatives with immunosuppressant activity
05/07/1997EP0727941A4 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
04/1997
04/24/1997WO1997014672A1 Triciclic compounds
04/24/1997WO1997014670A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof
04/23/1997EP0769007A1 2-ureido-benzamide derivatives
04/23/1997EP0623123B1 Benzopyran and related LTB4-antagonists
04/16/1997EP0767788A1 New brefeldin a derivatives and their utility in the treatment of cancer
04/09/1997EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
04/02/1997EP0765879A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests
04/02/1997EP0765873A1 Cyclic ureas and analogues useful as retroviral protease inhibitors
03/1997
03/30/1997CA2186650A1 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and others pests
03/25/1997US5614550 Anticholesterol agents or arteriosclerosis agents for humans
03/12/1997EP0761662A1 Method for preparing unsaturated cyclic ethers
03/11/1997US5610294 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
03/05/1997EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
03/05/1997EP0623122B1 Benzopyran and related LTB4-antagonists.
02/1997
02/26/1997EP0759443A2 Hydroxy-substituted monolactones useful as intermediates for preparing lubricating oil and fuel additives
02/23/1997CA2183610A1 Hydroxy-substituted monolactones useful as intermediates for preparing lubricating oil and fuel additives
02/20/1997WO1996039147A3 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
02/11/1997US5602152 Benzoxepines
02/06/1997WO1997003979A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
02/06/1997WO1997003978A1 Novel heterocyclic compounds for the treatment of pain and use thereof
02/06/1997CA2223646A1 Novel heterocyclic compounds for the treatment of pain and use thereof
02/06/1997CA2223644A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
01/1997
01/23/1997WO1997002358A1 Cell-free synthesis of polyketides
01/16/1997WO1997001334A1 Cytotoxic triterpenes from a marine sponge
01/09/1997WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
01/09/1997WO1997000853A1 Bicyclic amino derivatives and pgd2 antagonist containing the same
01/07/1997US5591884 Dopamine agonists
01/07/1997US5591772 Dietary supplements
01/03/1997WO1997000265A1 Synthetic modification to spinosyn compounds
01/01/1997CN1139431A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
12/1996
12/19/1996WO1996040671A1 Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
12/19/1996WO1996040101A1 Certain arylsulfonamido-substituted hydroxamic acids for the treatment of certain tumors
12/12/1996WO1996039147A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
12/05/1996WO1996038437A1 Process for the production of lipoic acid
12/04/1996CN1137039A Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines
11/1996
11/13/1996EP0742208A1 2-Ureido-benzamide derivatives
11/12/1996US5574173 Inhibitors of tumor necrosis factor
11/07/1996WO1996034856A1 2-ureido-benzamide derivatives
11/07/1996CA2194481A1 2-ureido-benzamide derivatives
10/1996
10/31/1996WO1996033989A1 Radicicol derivatives
10/16/1996EP0737189A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders
10/16/1996CN1032999C increasing yield of cereals by means of brassinolide derivatives
10/01/1996US5561060 Having pharmacological applicability
10/01/1996CA1338625C Tricyclic compounds
09/1996
09/25/1996EP0733049A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them
09/03/1996US5552435 Benzopyran and related LTB antagonists
09/03/1996US5552419 Arylsulfonamido-substituted hydroxamic acids
08/1996
08/29/1996WO1996025927A1 Glutamic acid receptor blocker and cerebral function ameliorant
08/28/1996EP0727942A1 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds
08/28/1996EP0727941A1 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
08/27/1996US5550152 Antiinflammatory agents
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/14/1996EP0726265A1 10-Aminoaliphatyl-dibenz(b,f)oxepins with antineurodegenarative activity
08/14/1996EP0725784A1 DIBENZO [b,e]OXEPINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND MEDICAMENTS CONTAINING THEM
08/01/1996WO1996013259A3 Method and compositions for inhibiting protein kinases
07/1996
07/23/1996US5539089 Insecticides using macrolides
07/23/1996US5538986 Tricyclic derivatives, compositions and methods of use
07/18/1996WO1996021638A1 Novel compounds
07/11/1996WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
07/11/1996CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases
07/09/1996US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
06/1996
06/25/1996US5530021 Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
06/25/1996CA1338416C Muscarinic receptor antagonists
06/18/1996US5527769 Aromatic compounds and their use in perfumery
06/04/1996US5523319 Compounds of the benzo-heterocycle family
05/1996
05/14/1996US5516921 Thiono-lactone inhibitors of protein trafficking and uses therefor
05/09/1996WO1996013259A2 Method and compositions for inhibiting protein kinases
05/09/1996CA2203757A1 Method and compositions for inhibiting protein kinases
05/07/1996US5514642 Herbicides for plant growth regulators
04/1996
04/09/1996US5506355 Method for preparing cyclic sulfamides and their use for the synthesis of HIV protease inhibitors
04/09/1996US5506242 Arylsufonamido-substituted hydroxamic acids
04/04/1996WO1996010021A1 Novel antioxidant tricyclic fused heterocyclic compound
04/03/1996EP0703912A1 Process for producing lactones and lactones obtained with this process
04/03/1996EP0703892A1 Process for producing an omega-functionalized aliphatic carboxylic acid and intermediate products of said process
04/02/1996US5504260 Selective reaction with elemental oxygen in presence of carbon monoxide and palladium-copper catalyst
03/1996
03/28/1996WO1996009299A1 Drugs to improved synaptic transmission
02/1996
02/27/1996US5495022 Antiarrhythmic, isotropic agents
02/21/1996EP0474767B1 Dopamine agonists
02/15/1996WO1996000726A3 New brefeldin a derivatives and their utility in the treatment of cancer
02/06/1996US5489694 Reacting cyclohexanone with alkyl vinyl ether, oxidizing, reacting with thiourea, cyclizing distilling
01/1996
01/31/1996CN1115759A Tricyclic carboxylate
01/11/1996WO1996000726A2 New brefeldin a derivatives and their utility in the treatment of cancer
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36